166 related articles for article (PubMed ID: 20175870)
1. Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura.
McDonald V; Manns K; Mackie IJ; Machin SJ; Scully MA
J Thromb Haemost; 2010 Jun; 8(6):1201-8. PubMed ID: 20175870
[TBL] [Abstract][Full Text] [Related]
2. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ
Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
[TBL] [Abstract][Full Text] [Related]
3. Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.
Becerra E; Scully MA; Leandro MJ; Heelas EO; Westwood JP; De La Torre I; Cambridge G
Clin Exp Immunol; 2015 Mar; 179(3):414-25. PubMed ID: 25339550
[TBL] [Abstract][Full Text] [Related]
4. More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura.
Vazquez-Mellado A; Pequeño-Luévano M; Cantu-Rodriguez OG; Villarreal-Martínez L; Jaime-Pérez JC; Gomez-De-Leon A; De La Garza-Salazar F; Gonzalez-Llano O; Colunga-Pedraza P; Sotomayor-Duque G; Gomez-Almaguer D
Hematology; 2016 Jun; 21(5):311-6. PubMed ID: 26907228
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
Rubia J; Moscardó F; Gómez MJ; Guardia R; Rodríguez P; Sebrango A; Zamora C; Debén G; Goterris R; López R; Peña F; Pujol M; Vidaller A; Río-Garma JD; Sanz MA;
Transfus Apher Sci; 2010 Dec; 43(3):299-303. PubMed ID: 20934383
[TBL] [Abstract][Full Text] [Related]
6. Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases.
Pequeño-Luévano M; Villarreal-Martínez L; Jaime-Pérez JC; Gómez-de-León A; Cantú-Rodríguez OG; González-Llano O; Gómez-Almaguer D
Hematology; 2013 Jul; 18(4):233-6. PubMed ID: 23432850
[TBL] [Abstract][Full Text] [Related]
7. Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series.
Arcudi S; Ferrari B; Pontiggia S; Tufano A; Artoni A; Mancini I; Peyvandi F
J Thromb Haemost; 2019 Mar; 17(3):492-498. PubMed ID: 30629316
[TBL] [Abstract][Full Text] [Related]
8. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.
Caramazza D; Quintini G; Abbene I; Malato A; Saccullo G; Lo Coco L; Di Trapani R; Palazzolo R; Barone R; Mazzola G; Rizzo S; Ragonese P; Aridon P; Abbadessa V; Siragusa S
Transfusion; 2010 Dec; 50(12):2753-60. PubMed ID: 20576013
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes.
George JN; Al-Nouri ZL
Hematology Am Soc Hematol Educ Program; 2012; 2012():604-9. PubMed ID: 23233641
[TBL] [Abstract][Full Text] [Related]
10. Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
Wieland I; Kentouche K; Jentzsch M; Lothschütz D; Graf N; Sykora KW
Pediatr Blood Cancer; 2015 May; 62(5):823-9. PubMed ID: 25623397
[TBL] [Abstract][Full Text] [Related]
11. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
Som S; Deford CC; Kaiser ML; Terrell DR; Kremer Hovinga JA; Lämmle B; George JN; Vesely SK
Transfusion; 2012 Dec; 52(12):2525-32; quiz 2524. PubMed ID: 22501034
[TBL] [Abstract][Full Text] [Related]
12. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.
Scully M; McDonald V; Cavenagh J; Hunt BJ; Longair I; Cohen H; Machin SJ
Blood; 2011 Aug; 118(7):1746-53. PubMed ID: 21636861
[TBL] [Abstract][Full Text] [Related]
13. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.
Rüfer A; Brodmann D; Gregor M; Kremer Hovinga JA; Lämmle B; Wuillemin WA
Swiss Med Wkly; 2007 Sep; 137(37-38):518-24. PubMed ID: 17990141
[TBL] [Abstract][Full Text] [Related]
14. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura.
Underwood MI; Alwan F; Thomas MR; Scully MA; Crawley JTB
J Thromb Haemost; 2023 Jun; 21(6):1544-1552. PubMed ID: 36813118
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
[TBL] [Abstract][Full Text] [Related]
17. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.
Ling HT; Field JJ; Blinder MA
Am J Hematol; 2009 Jul; 84(7):418-21. PubMed ID: 19507208
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.
Zhou X; Ye X; Ren Y; Mei C; Ma L; Huang J; Xu W; Wei J; Ye L; Mai W; Qian W; Meng H; Jin J; Tong H
Front Med; 2016 Dec; 10(4):430-436. PubMed ID: 27878664
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse.
Westwood JP; Webster H; McGuckin S; McDonald V; Machin SJ; Scully M
J Thromb Haemost; 2013 Mar; 11(3):481-90. PubMed ID: 23279219
[TBL] [Abstract][Full Text] [Related]
20. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
Goyal J; Adamski J; Lima JL; Marques MB
J Clin Apher; 2013 Dec; 28(6):390-4. PubMed ID: 23857472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
